|
🐜
|
Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study.
14 auth.
B. Coiffier,
S. Leprêtre,
L. Pedersen,
O. Gadeberg,
Henrik Fredriksen,
M. V. van Oers,
J. Wooldridge,
J. Kłoczko,
J. Hołowiecki,
A. Hellmann,
...
J. Walewski,
M. Flensburg,
J. Petersen,
T. Robak
|
8 |
2008 |
8
🐜
|
|
🐜
|
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.
20 auth.
Y. Chalandon,
X. Thomas,
S. Hayette,
J. Cayuela,
C. Abbal,
F. Huguet,
E. Raffoux,
T. Leguay,
P. Rousselot,
S. Leprêtre,
...
M. Escoffre-barbe,
S. Maury,
C. Berthon,
E. Tavernier,
J. Lambert,
M. Lafage-Pochitaloff,
V. Lheritier,
S. Chevret,
N. Ifrah,
H. Dombret
|
8 |
2015 |
8
🐜
|
|
🐜
|
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
24 auth.
J. Byrd,
P. Hillmen,
P. Ghia,
A. Kater,
A. Chanan-Khan,
R. Furman,
S. O'brien,
M. Yenerel,
Á. Illés,
N. Kay,
...
J. García-Marco,
A. Mato,
J. Pinilla-Ibarz,
J. Seymour,
S. Leprêtre,
S. Stilgenbauer,
T. Robak,
Wayne Rothbaum,
R. Izumi,
A. Hamdy,
P. Patel,
K. Higgins,
S. Sohoni,
W. Jurczak
|
8 |
2021 |
8
🐜
|
|
🐜
|
Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study
12 auth.
V. Goede,
K. Fischer,
A. Engelke,
R. Schlag,
S. Leprêtre,
L. F. C. Montero,
...
M. Montillo,
Christopher Fegan,
E. Asikanius,
Kathryn Humphrey,
G. Fingerle-Rowson,
Michael Hallek
|
7 |
2015 |
7
🐜
|
|
🐜
|
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.
19 auth.
H. Döhner,
M. Lübbert,
W. Fiedler,
L. Fouillard,
A. Haaland,
J. Brandwein,
S. Leprêtre,
O. Reman,
P. Turlure,
O. Ottmann,
...
C. Müller-Tidow,
A. Krämer,
E. Raffoux,
K. Döhner,
R. Schlenk,
F. Voß,
T. Taube,
H. Fritsch,
J. Maertens
|
7 |
2014 |
7
🐜
|
|
🐜
|
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
43 auth.
R. Kreitman,
C. Dearden,
P. Zinzani,
J. Delgado,
L. Karlin,
T. Robak,
D. Gladstone,
P. le Coutre,
S. Dietrich,
M. Gotic,
L. Larratt,
F. Offner,
G. Schiller,
R. Swords,
Larry Bacon,
...
M. Bocchia,
K. Bouabdallah,
D. Breems,
A. Cortelezzi,
S. Dinner,
M. Doubek,
B. Gjertsen,
M. Gobbi,
A. Hellmann,
S. Leprêtre,
F. Maloisel,
F. Ravandi,
P. Rousselot,
M. Rummel,
T. Siddiqi,
T. Tadmor,
X. Troussard,
C. A. Yi,
G. Saglio,
G. Roboz,
K. Balic,
N. Standifer,
Peng He,
S. Marshall,
W. Wilson,
I. Pastan,
N. Yao,
F. Giles
|
7 |
2018 |
7
🐜
|
|
🐜
|
Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
10 auth.
H. Lanic,
Jérôme Kraut-Tauzia,
R. Modzelewski,
F. Clatot,
S. Mareschal,
J. Picquenot,
...
A. Stamatoullas,
S. Leprêtre,
H. Tilly,
F. Jardin
|
7 |
2014 |
7
🐜
|
|
🐜
|
Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
20 auth.
Jonathan Bond,
C. Graux,
L. Lhermitte,
D. Lara,
T. Cluzeau,
T. Leguay,
A. Cieslak,
A. Trinquand,
C. Pastoret,
Mohamed Belhocine,
...
S. Spicuglia,
V. Lheritier,
S. Leprêtre,
X. Thomas,
F. Huguet,
N. Ifrah,
H. Dombret,
E. Macintyre,
N. Boissel,
V. Asnafi
|
7 |
2017 |
7
🐜
|
|
🐜
|
Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO).
21 auth.
Laurence Simon,
A. Fitsiori,
R. Lemal,
J. Dupuis,
B. Carpentier,
L. Boudin,
A. Corby,
T. Aurran-Schleinitz,
L. Gastaud,
A. Talbot,
...
S. Leprêtre,
B. Mahé,
Camille Payet,
C. Soussain,
C. Bonnet,
L. Vincent,
S. Lissandre,
R. Herbrecht,
S. Kremer,
V. Leblond,
L. Fornecker
|
7 |
2015 |
7
🐜
|
|
🐜
|
Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia.
17 auth.
O. Tournilhac,
B. Cazin,
S. Leprêtre,
M. Diviné,
K. Maloum,
A. Delmer,
B. Grosbois,
P. Feugier,
F. Maloisel,
F. Villard,
...
B. Villemagne,
D. Bastit,
K. Belhadj,
N. Azar,
M. Michallet,
G. Manhes,
P. Travade
|
6 |
2004 |
6
🐜
|
|
🦁
|
Prolonged local antibiotics delivery from hydroxyapatite functionalised with cyclodextrin polymers.
8 auth.
S. Leprêtre,
F. Chai,
J. Hornez,
G. Vermet,
C. Neut,
M. Descamps,
...
H. Hildebrand,
B. Martel
|
6 |
2009 |
6
🦁
|
